Q3 2025 Holdings
Filed 2025-11-14 | 51 holdings | $106.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $11.0M | 8,753,290 | 10.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $10.4M | 108,404 | 9.8% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $9.3M | 2,139,000 | 8.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $7.1M | 750,000 | 6.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $7.0M | 132,805 | 6.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $6.7M | 175,600 | 6.3% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $6.2M | 2,668,395 | 5.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $5.5M | 64,389 | 5.1% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $5.2M | 2,143,698 | 4.9% |
| Zooz PWR LTD | SHARE | M2573A106 | $4.3M | 2,000,000 | 4.0% |
| Alumis Inc(ALMS) | COM | 022307102 | $3.8M | 946,683 | 3.5% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $3.8M | 73,545 | 3.5% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $3.4M | 263,642 | 3.1% |
| Sutro Biopharma Inc | COM | 869367102 | $2.7M | 3,120,000 | 2.5% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $2.1M | 352,000 | 2.0% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $2.1M | 79,977 | 1.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.0M | 130,000 | 1.9% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $1.9M | 205,000 | 1.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.9M | 32,000 | 1.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.9M | 86,500 | 1.8% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $1.7M | 687,500 | 1.6% |
| Tela BIO Inc(TELA) | COM | 872381108 | $1.1M | 747,410 | 1.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $898.7K | 346,973 | 0.8% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $771.7K | 61,000 | 0.7% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $634.2K | 83,333 | 0.6% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $277.4K | 5,800 | 0.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $255.2K | 80,000 | 0.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $245.8K | 3,700 | 0.2% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $224.2K | 6,500 | 0.2% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $208.0K | 160,000 | 0.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $184.1K | 70,000 | 0.2% |
| Alector Inc(ALEC) | COM | 014442107 | $162.8K | 55,000 | 0.2% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $150.6K | 20,000 | 0.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $150.2K | 20,000 | 0.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $147.8K | 16,000 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $141.7K | 65,000 | 0.1% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $124.4K | 40,000 | 0.1% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $122.1K | 55,000 | 0.1% |
| Immunome Inc(IMNM) | COM | 45257U108 | $117.1K | 10,000 | 0.1% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $110.4K | 20,000 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $109.8K | 15,000 | 0.1% |
| Geron Corp(GERN) | COM | 374163103 | $109.6K | 80,000 | 0.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $106.6K | 33,000 | 0.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $96.9K | 100,000 | 0.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $95.9K | 45,000 | 0.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $83.8K | 20,000 | 0.1% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $73.2K | 35,000 | 0.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $62.1K | 32,700 | 0.1% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $49.0K | 35,000 | 0.0% |